Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade

Reference:
Size

,

Isotype

hG1-Fc

Brand

Product type

Clonality

Expression system

Applications

,

Product nameAbatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade
SourceDrugBank DB01281
SpeciesHuman
Molecular weight92kDa
Purity>85%
BufferPBS pH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAbatacept,Abatacept,CTLA-4 extracellular domain linked to IgG1 Fc,anti-CTLA-4 extracellular domain linked to IgG1 Fc
ReferencePX-TA1020
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypehG1-Fc
ClonalityMonoclonal Antibody

Description of Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade

General information about Abatacept

Abatacept est une protéine de fusion composée du domaine extracellulaire de l’antigène 4 cytotoxique humain associé au lymphocyte T (CTLA-4) lié à une partie Fc modifiée d’immunoglobuline humaine (IgG1) qui inhibe le signal de co-stimulation CD80/86 nécessaire à l’activation des lymphocytes T exprimant le CD28. This product is for research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Tumor-associated calcium signal transducer 2(TACSTD2)
Antigen

Tumor-associated calcium signal transducer 2(TACSTD2)

PX-P4569 250$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products